Literature DB >> 34093749

MicroRNA-296-5p inhibits cell proliferation by targeting HMGA1 in colorectal cancer.

Guohui Yan1,2,3, Shuidi Yan4, Jiajia Wang4, Shen Lei2, Weimin Tian5, Xin Yue6, Yang Zhang1,2,4.   

Abstract

An increasing body of evidence indicates the involvement of microRNAs (miRNAs/miRs) in the initiation and progression of colorectal cancer (CRC). miR-296-5p was recently identified as a tumor suppressor in a variety of human cancer types; however, its function in CRC remains largely unknown. The present study demonstrated that the expression of miR-296-5p was significantly downregulated in CRC tissues and cell lines. The overexpression of miR-296-5p markedly inhibited proliferation, and induced cell cycle arrest and apoptosis in CRC cells. Bioinformatics analysis suggested that high mobility group AT-hook 1 (HMGA1) may be a target of miR-296-5p in CRC cells. Further experiments showed that miR-296-5p bound the 3'-untranslated region of HMGA1 and decreased its expression in CRC cells. HMGA1 was overexpressed in CRC tissues and was inversely correlated with the expression of miR-296-5p. The restoration of HMGA1 significantly reversed the inhibitory effect of miR-296-5p on the proliferation of CRC cells. Overall, the findings of the present study indicate that miR-296-5p suppressed the progression of CRC, at least partially via targeting HMGA1. Thus, miR-296-5p is a potential target for novel therapies in CRC.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  cell cycle; colorectal cancer; high mobility group AT-hook 1; microRNA-296-5p

Year:  2021        PMID: 34093749      PMCID: PMC8170657          DOI: 10.3892/etm.2021.10225

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  46 in total

1.  miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.

Authors:  Wen-bin Zhou; Cai-neng Zhong; Xun-peng Luo; Ya-yuan Zhang; Gui-ying Zhang; Dong-xian Zhou; Li-ping Liu
Journal:  Biochem Biophys Res Commun       Date:  2016-01-22       Impact factor: 3.575

Review 2.  Circulating miRNAs: promising biomarkers of human cancer.

Authors:  Hongguang Qu; Weiwei Xu; Yuchuan Huang; Shujuan Yang
Journal:  Asian Pac J Cancer Prev       Date:  2011

3.  Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.

Authors:  Xiu-Peng Jia; Ling-Li Meng; Jian-Chen Fang; Hong-Wei Wang; Jie Chen; Jue Zhou; Chun-Nian Wang; Wei-Feng Jiang
Journal:  Clin Lab       Date:  2018-06-01       Impact factor: 1.138

4.  Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.

Authors:  Xiaowen Zhang; Tao Tao; Chunhui Liu; Han Guan; Yeqing Huang; Bin Xu; Ming Chen
Journal:  Oncol Rep       Date:  2016-05-09       Impact factor: 3.906

Review 5.  Metastatic colorectal cancer: current state and future directions.

Authors:  Marwan G Fakih
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

6.  NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

Authors:  Al B Benson; Alan P Venook; Mahmoud M Al-Hawary; Lynette Cederquist; Yi-Jen Chen; Kristen K Ciombor; Stacey Cohen; Harry S Cooper; Dustin Deming; Paul F Engstrom; Ignacio Garrido-Laguna; Jean L Grem; Axel Grothey; Howard S Hochster; Sarah Hoffe; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Jeffrey Meyerhardt; Eric D Miller; Mary F Mulcahy; James D Murphy; Steven Nurkin; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Evan Wuthrick; Kristina M Gregory; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-04       Impact factor: 11.908

7.  MiR-26b regulates 5-FU-resistance in human colorectal cancer via down-regulation of Pgp.

Authors:  Bin Wang; Fen-Ying Lu; Rui-Hua Shi; Ya-Dong Feng; Xiao-Dan Zhao; Zhi-Ping Lu; Long Xiao; Guo-Qiang Zhou; Jia-Ming Qiu; Cui-E Cheng
Journal:  Am J Cancer Res       Date:  2018-12-01       Impact factor: 6.166

Review 8.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

9.  Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.

Authors:  H Lopez-Bertoni; B Lal; N Michelson; H Guerrero-Cázares; A Quiñones-Hinojosa; Y Li; J Laterra
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

Review 10.  Colorectal cancer development and advances in screening.

Authors:  Karen Simon
Journal:  Clin Interv Aging       Date:  2016-07-19       Impact factor: 4.458

View more
  1 in total

1.  Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma.

Authors:  Ju A Son; Hye Ri Ahn; Donglim You; Geum Ok Baek; Moon Gyong Yoon; Jung Hwan Yoon; Hyo Jung Cho; Soon Sun Kim; Suk Woo Nam; Jung Woo Eun; Jae Youn Cheong
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.